Hypercholesterolemia is associated with the atherosclerotic process and cardiovascular disease from childhood, thus introducing the need of an early prevention. The dietary approach is the treatment cornerstone but sometimes is unsuccessful to reach the lipoprotein optimal target. Furthermore, drugs like statins have limited use in childhood as their administration is limited to high risk children. The effects of nutraceuticals are known in adults and considered useful in children to overcome this therapy gap. In the present paper a review of pediatric expe riences from fiber, phytosterols and RYR hand ing out is considered.
Landmesser, U., Hornig, B. and Drexler, H. (2004) Endothelial function: A critical determinant in atherosclerosis? Circulation, 109, 27-33. doi:10.1161/01.CIR.0000129501.88485.1f
(2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics, 128, 213-256. doi:10.1542/peds.2009-2107C
Sanchez-Bayle, M., Gon-zalez-Requejo, A., Asensio-Anton, J., Ruiz-Jarabo, C., Fer-nandez-Ruiz, M.L. and Baeza, J. (2001) The effect of fiber supplementation on lipid profile in children with hypercholes-terolemia. Clinical Pediatrics, 40, 291-294. doi:10.1177/000992280104000511
Katan, M.B., Grundy, S.M., Jones, P., Law, M., Miettinen, T. and Paoletti, R. (2003) Efficacy and safety of plant stanols and sterols in the manage-ment of blood cholesterol levels. Mayo Clinic Proceeding, 78, 965-978.
Subcommittee on the Tenth Edition of the Recommended Dietary Allowances, Food and Nutrition Board, Commission on Life Sciences, National Research Council (1989) Recommended dietary allowances. 10th Edition, Washington DC, 39-43.
Williams, C.L., Bollella, M. and Wynder, E.L. (1995) A new recommendation for dietary fiber in childhood. Pediatrics, 96, 985-988.
American Academy of Pediatrics, Committee on Nutrition (1993) Carbohydrate and dietary fiber. In: Barness, L., Ed., Pediatric Nutrition Handbook, 3rd Edition, American Academy of Pediatrics, Elk Grove, 100-106.
Guardamagna, O., Abello, F. and Visioli, F. (2013) Could dyslipidemic children benefit from glucomannan intake? Nutrition, in press. doi:10.1016/j.nut.2013.02.010
Martino, F., Martino, E., Morrone, F., Carnevali, E., Forcone, R. and Niglio, T. (2005) Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children. Nutrition Metabolism and Cardiovascular Diseases, 15, 174-180. doi:10.1016/j.numecd.2004.04.004
Sood, N., Baker, W.L. and Coleman, C.I. (2008) Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. American Journal of Clinical Nutrition, 88, 1167-1175.
Williams, C.L., Bollella, M.C., Strobino, B.A., Boccia, L. and Campanaro, L. (1999) Plant stanol ester and bran fiber in childhood: Effects on lipids, stool weight and stool frequency in preschool children. Journal of American College of Nutrition, 18, 572-581. doi:10.1080/07315724.1999.10718891
Taneja, A., Bhat, C.M., Arora, A. and Kaur, A.P. (1989) Effect of incorporation of isabgol husk in a low fibre diet on faecal excretion and serum levels of lipids in adolescent girls. European Journal of Clinical Nutrition, 43, 197-202.
Glassman, M., Spark, A., Berezin, S., Schwarz, S., Medow, M. and Newman, L.J. (1990) Treatment of type IIa hyperlipidemia in childhood by a simplified American Heart Association diet and fiber supplementation. American Journal of Diseases of Children, 144, 973-976.
Guardamagna, O., Baracco, V. and Abello, F. (2009) Le dislipidemie in pediatria. Johan & Levi Editore, Milano, 1-143.
Ruottinen, S., Lagstr?m, H.K., Niinikoski, H., R?nnemaa, T., Saarinen, M., Pahkala, K.A., Hakanen, M., Viikari, J.S. and Simell, O. (2010) Dietary fiber does not displace energy but is associated with decreased serum cholesterol concentrations in healthy children. The American Journal of Clinical Nutrition, 91, 651-661. doi:10.3945/ajcn.2009.28461
Davidson, M.H., Dugan, L.D., Burns, J.H., Sugimoto, D., Story, K. and Drennan, K. (1996) A psyllium enriched cereal for the treatment of hyper-cholesterolemia in children: A controlled, double-blind, crossover study. American Journal of Clinical Nutrition, 63, 96-l02.
Dennison, B.A. and Levine, D.M. (1993) Ran-domised, double blind, placebo controlled, two-period crossover clinical trial of psyllium fiber in children with hypercho-lesterolemia. The Journal of Pediatrics, 123, 24-29. doi:10.1016/S0022-3476(05)81532-X
De Smet, E., Men-sink, R.P. and Plat, J. (2012) Effects of plant sterols and stanols on intestinal cholesterol metabolism: Suggested mechanisms from past to present. Mo- lecular Nutrition and Food Research, 56, 1058-1072. doi:10.1002/mnfr.201100722
Gylling, H., Siimes, M.A. and Miettinen, T.A. (1995) Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. Journal of lipid researche, 36, 1807-1812.
Tammi, A., R?nnemaa, T., Miettinen, T.A., Gylling, H., Rask-Nissil?, L., Viikari, J., Tuominen, J., Marniemi, J. and Simell, O. (2002) Effect of gender, ApoE phenotype and cholesterol-lowering by plant stanol esters in children: The STRIP study. Acta Paediatrica, 91, 1155-1162. doi:10.1111/j.1651-2227.2002.tb00121.x
Garaiova, I., Muchová, J., Nagyová, Z., Mi??anová, C., Oravec, S., Dukát, A., Wang, D., Plummer, S.F. and ?u- ra?ková, Z. (2013) Effect of a plant sterol, fish oil and B vitamin combination in cardiovascular risk factors in hy- percholesterolemic children and adolescent: A pilot study. Nutrition Journal, 8, 12-17.
Amundsen, A.L., Ntanios, F., Put, N. and Ose, L. (2004) Long term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with familial hypercholesterolemia consuming plant sterol es- ter enriched spread. European Journal of Clinical Nutri- tion, 58, 1612-1620. doi:10.1038/sj.ejcn.1602015
De Jongh, S., Vissers, M.N., Rol, P., Bakker, H.D., Kastelein, J.J. and Stroes, E.S. (2003) Plant sterols lower LDL-C without improving endothelial function in prepu- beral children with familial hyper-cholesterolemia. Jour- nal of Inherit Metabolic Disease, 26, 343-351. doi:10.1023/A:1025155002348
Becker, M., Staab, D. and Von Bergmann, K. (1993) Treat- ment of severe familial hyper-cholesterolemia in child- hood with sitostenol and sitostanol. Journal of Pediatrics, 122, 292-296. doi:10.1016/S0022-3476(06)80136-8
Genser, B., Sil-bernagel, G., De Backer, G., Bruckert, E., Carmena, R., Chapman, M.J., Deanfield, J., Descamps, O.S., Rietzschel, E.R., Dias, K.C. and M?rz, W. (2012) Plant ster- ols and cardiovascular disease: A systematic review and meta-analysis. European Heart Journal, 33, 444-451. doi:10.1093/eurheartj/ehr441
Gylling, H., Hallikainen, M., Nissinen, M.J. and Miettinen, T.A. (2010) The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat- soluble vitamins. Clinical Nutrition, 29, 112-118. doi:10.1016/j.clnu.2009.08.005
Guardamagna, O., Abello, F., Baracco, V., Federici, G., Bertucci, P., Mozzi, A., Mannucci, L., Gnasso, A. and Cortese, C. (2011) Primary hyperlipidemias in children: Effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption. Acta Diabetologica, 48, 127-133. doi:10.1007/s00592-010-0233-1
Jakulj, L., Vissers, M.N., Rodenburg, J., Wiegman, A., Trip, M.D. and Kastelein, J.J. (2006) Plant stanols do not restore endothelial function in pre-puberal children with familial hypercholesterolemia despite reduction of LDL- C levels. Journal of Pediatrics, 148, 495-500. doi:10.1016/j.jpeds.2005.11.023
Amundsen, A.L., Ose, L., Nenseter, M.S. and Ntanios, F.Y. (2002) Plant sterol es-ter-enriched spread lowers plas- ma total and LDL cholesterol in children with familial hypercholesterolemia. The American Journal of Clinical Nutrition, 76, 338-344.
Ma, J., Li, Y., Ye, Q., Li, J., Hua, Y., Ju, D., Zhang, D., Cooper, R. and Chang, M. (2000) Constituents of red yeast rice, a traditional Chinese food and medicine. Jour- nal of Agricultural and Food Chem-istry, 48, 5220-5225. doi:10.1021/jf000338c
Journoud, M. and Jones, P.J. (2004) Red yeast rice: A new hypolipidemic drug. Life Sciences, 74, 2675-2683. doi:10.1016/j.lfs.2003.10.018
Wang, J., Lu, Z., Chi, J., Wang, W., Su, M., Kou, W., Yu, P., Yu, L., Chen, L., Zhu, J.S. and Chang, J. (1997) Mul- ticenter clinical trial of the serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Current Thera-peutic Re- search, 58, 964-978.
Heber, D., Yip, I., Ashley, J.M., Elashoff, D.A., Elashoff, R.M. and Go, V.L. (1999) Cho-lesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. American Journal of Clinical Nutrition, 69, 231-236.
Lin, C.C., Li, T.C. and Lai, M.M. (2005) Effi-cacy and safety of Monascus purpureus went rice in subjects with hyperlipidemia. European Journal of Endocrinology, 153, 679-686. doi:10.1530/eje.1.02012
Guardamagna, O., Abello, F., Baracco, V., Stasiowska, B. and Martino, F. (2011) The treatment of hypercholes- terolemic children: Efficacy and safety of a combination of red yeast rice extract and policosanols. Nutrition, Metabolism & Cardiovascular Diseases, 21, 424-429. doi:10.1016/j.numecd.2009.10.015
Smith, D.J. and Olive, K.E. (2003) Chinese red rice-in- duced myopathy. Southern Medical Journal, 96, 1265- 1267. doi:10.1097/01.SMJ.0000100117.79718.DC
Yang, C.W. and Mousa, S.A. (2012) The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders. Complementary Therapies in Medicine, 20, 466-474. doi:10.1016/j.ctim.2012.07.004
Jones, M.L., Tomaro-Duchesneau, C., Martoni, C.J. and Prakash, S. (2013) Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health ap- plications. Expert Opinion of Bio-logical Therapy, 13, 631-642. doi:10.1517/14712598.2013.758706
Schaafsma, G., Meu-ling, W.J., Van Dokkum, W. and Bou- ley, C. (1998) Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccha- rides added, on blood lipids in male volunteers. European Journal of Clinical Nutrition, 52, 436-440. doi:10.1038/sj.ejcn.1600583
Bertolami, M.C., Faludi, A.A. and Batlouni, M. (1999) Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. European Jour- nal of Clinical Nutrition, 53, 97-101. doi:10.1038/sj.ejcn.1600683
Agerbaek, M., Gerdes, L.U. and Richelsen, B. (1995) Hy- pocholesterolaemic effect of a new fermented milk prod- uct in healthy middle-aged men. European Journal of Clinical Nutrition, 49, 346-352.
Jones, M.L., Martoni, C.J., Parent, M. and Prakash, S. (2011) Cholesterol-lowering efficacy of a microencapsu- lated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterol- aemic adults. British Journal of Nutrition, 107, 1505- 1513. doi:10.1017/S0007114511004703
Jones, M.L., Martoni, C.J. and Prakash, S. (2012) Cho- lesterol lowering and inhibi-tion of sterol absorption by Lactobacillus reuteri NCIMB 30242: A randomized con- trolled trial. European Journal of Clinical Nutrition, 66, 1234-1241. doi:10.1038/ejcn.2012.126
Ooi, L.G., Ahmad, R., Yuen, K.H. and Liong, M.T. (2011) Lactobacillus acidophilus CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cho- lesterol via alteration of lipid transporters. Journal of Dairy Science, 93, 5048-5058. doi:10.3168/jds.2010-3311
(2008) Scientific opinion of the panel on dietetic products nutrition and allergies on a request from unilever PLC/ NV on plant Sterols and lower/reduced blood cholesterol, reduced the risk of (coronary) heart disease. The EFSA Journal, 781, 1-12.